![Capricor Therapeutics](/static/img/stocks/capr.png) |
Capricor Therapeutics
CAPR
|
$ 15.19 |
12.69 % |
$ 407 M |
Nasdaq Capital Market |
USA |
![Sorrento Therapeutics](/static/img/stocks/srne.png) |
Sorrento Therapeutics
SRNE
|
$ 0.27 |
-29.58 % |
$ 126 M |
Nasdaq Global Select Market |
USA |
![ContraFect Corporation](/static/img/stocks/cfrx.png) |
ContraFect Corporation
CFRX
|
$ 1.47 |
-5.16 % |
$ 5.39 M |
Nasdaq Capital Market |
USA |
![Orchard Therapeutics plc](/static/img/stocks/ortx.png) |
Orchard Therapeutics plc
ORTX
|
$ 4.93 |
1.02 % |
$ 90.8 M |
Nasdaq Global Select Market |
Britain |
![Advaxis](/static/img/stocks/adxs.png) |
Advaxis
ADXS
|
$ 0.31 |
-9.65 % |
$ 45.9 M |
Nasdaq Capital Market |
USA |
![Heat Biologics, Inc.](/static/img/stocks/htbx.png) |
Heat Biologics, Inc.
HTBX
|
$ 3.93 |
-5.76 % |
$ 99.8 M |
Nasdaq Capital Market |
USA |
![Cyclacel Pharmaceuticals](/static/img/stocks/cyccp.png) |
Cyclacel Pharmaceuticals
CYCCP
|
$ 6.6 |
- |
$ 6.99 M |
Nasdaq Capital Market |
USA |
![La Jolla Pharmaceutical Company](/static/img/stocks/ljpc.png) |
La Jolla Pharmaceutical Company
LJPC
|
$ 6.2 |
- |
$ 154 M |
Nasdaq Capital Market |
USA |
![Zymeworks](/static/img/stocks/zyme.png) |
Zymeworks
ZYME
|
$ 6.42 |
- |
$ 404 M |
NYSE |
Canada |
![Checkmate Pharmaceuticals](/static/img/stocks/cmpi.png) |
Checkmate Pharmaceuticals
CMPI
|
$ 10.5 |
- |
$ 231 M |
Nasdaq Global Market |
USA |
![Kadmon Holdings, Inc.](/static/img/stocks/kdmn.png) |
Kadmon Holdings, Inc.
KDMN
|
$ 9.5 |
- |
$ 1.7 B |
Nasdaq Global Select Market |
USA |
![BioDelivery Sciences International](/static/img/stocks/bdsi.png) |
BioDelivery Sciences International
BDSI
|
$ 2.58 |
-4.8 % |
$ 255 M |
Nasdaq Global Select Market |
USA |
![Zosano Pharma Corporation](/static/img/stocks/zsan.png) |
Zosano Pharma Corporation
ZSAN
|
$ 0.56 |
7.23 % |
$ 2.72 M |
Nasdaq Global Select Market |
USA |
![Ayala Pharmaceuticals](/static/img/stocks/ayla.png) |
Ayala Pharmaceuticals
AYLA
|
$ 0.5 |
- |
$ 7.46 M |
Nasdaq Global Market |
Israel |
![Acceleron Pharma Inc.](/static/img/stocks/xlrn.png) |
Acceleron Pharma Inc.
XLRN
|
$ 179.68 |
- |
$ 10.9 B |
Nasdaq Global Market,SPB |
USA |
![Albireo Pharma](/static/img/stocks/albo.png) |
Albireo Pharma
ALBO
|
$ 44.15 |
-0.23 % |
$ 916 M |
Nasdaq Capital Market |
USA |
![Stealth BioTherapeutics Corp](/static/img/stocks/mito.png) |
Stealth BioTherapeutics Corp
MITO
|
$ 0.32 |
- |
$ 23.9 M |
Nasdaq Global Select Market |
USA |
![Trillium Therapeutics Inc.](/static/img/stocks/tril.png) |
Trillium Therapeutics Inc.
TRIL
|
$ 18.44 |
- |
$ 1.94 B |
Nasdaq Capital Market |
Canada |
![Akebia Therapeutics](/static/img/stocks/akba.png) |
Akebia Therapeutics
AKBA
|
$ 2.12 |
0.71 % |
$ 397 M |
Nasdaq Global Market |
USA |
![Kaleido Biosciences](/static/img/stocks/kldo.png) |
Kaleido Biosciences
KLDO
|
$ 0.29 |
-3.69 % |
$ 12.4 M |
Nasdaq Global Select Market |
USA |